4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid
![4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid price.](/StructureFile/ChemBookStructure3/GIF/CB2496175.gif)
|
- $378 - $874
- Product name: 4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid
- CAS: 330818-01-4
- MF: C14H13N3O3
- MW: 271.27
- EINECS:
- MDL Number:MFCD00652928
- Synonyms:4-([1]benzofuro[3,2-d]pyrimidin-4-ylamino)butanoic acid;4-(benzofuro[3,2-d]pyrimidin-4-ylamino)butanoic acid;TIMTEC-BB SBB012151;Butanoic acid, 4-(benzofuro[3,2-d]pyrimidin-4-ylamino)-;4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid
3 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 1.00g
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11143905
- Product description4-(Benzofuro[3,2-d]pyrimidin-4-ylamino)butanoic acid 97%
- Packaging5g
- Price$874
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number018391
- Product description4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018391
- Product description4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid
- Packaging1.00g
- Price$378
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11143905 | 4-(Benzofuro[3,2-d]pyrimidin-4-ylamino)butanoic acid 97% | 5g | $874 | 2026-05-26 | Buy |
| Matrix Scientific | 018391 | 4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid | 1g | $378 | 2021-12-16 | Buy |
| Matrix Scientific | 018391 | 4-(Benzo[4,5]furo[3,2-d]pyrimidin-4-ylamino)-butyric acid | 1.00g | $378 | 2026-05-18 | Buy |
Properties
Boiling point :555.6±40.0 °C(Predicted)
Density :1.423±0.06 g/cm3(Predicted)
pka :4.60±0.10(Predicted)
Density :1.423±0.06 g/cm3(Predicted)
pka :4.60±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|